Custom Lucite, with an embedded drug vial, celebrating FDA approval of Cosela. (20ADH005)
Custom Lucite, with an embedded drug vial, celebrating FDA approval of Cosela. (20ADH005)
Lucite commemorative, incorporating a drug vial, celebrating the first product shipment by generic pharmaceutical company Civica.
(9AKL475)Lucite deal toy recognizing the acquisition of Cincinnati-based Advanced Testing Laboratory. ATL provides research and development services in such areas as life science, product safety, and analytical chemistry. (22AJH077)
Custom financial tombstone recognizing a direct offering of common stock by Salarius Pharmaceuticals. The Houston-based firm develops cancer therapies. (22AJH070)
Lucite tombstone recognizing the acquisition of GeneTx BioTherapeutics. GeneTx has focused on a therapy for Angelman syndrome, a rare neurogenic disease. (22ALJ280)
This post is one in a series celebrating some of the deals and dealmakers in The Corporate...
Spinning Lucite tombstone celebrating the close of a fund by middle market private equity firm One Equity Partners. (22LJW093)
Crystal deal toy marking the acquisition of a royalty interest in global sales of pegcetacoplan, marketed under the brand names Empaveli and Aspavell. The drugs were developed for treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH), a rare blood disorder. (22AKL517)
